RCE 1.75% 58.0¢ recce pharmaceuticals ltd

Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection, page-104

  1. 5,257 Posts.
    lightbulb Created with Sketch. 679
    I meant "maybe Fiona Stanley are so impressed with phase 2 they will push for next phase asap due to unmet need."

    It would also be valuable I think if Recce refer directly to the QIDP and or FDA regarding future progress or plans at some stage.

    Hard to believe they just plan to sell this product in Australia but would be good to get official confirmation FDA is a target for either or both IV and burns? At this stage there still appear to be some who think they have decided against this path.
    I'm looking forward to seeing where this goes .
    Last edited by andrewk65: 07/01/22
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
58.0¢
Change
0.010(1.75%)
Mkt cap ! $116.2M
Open High Low Value Volume
57.0¢ 58.0¢ 57.0¢ $1.123K 1.966K

Buyers (Bids)

No. Vol. Price($)
2 72111 57.0¢
 

Sellers (Offers)

Price($) Vol. No.
58.0¢ 1872 1
View Market Depth
Last trade - 15.59pm 30/05/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.